قالب وردپرس درنا توس
Home / Health / High blood pressure drug recall: FDA warns of potentially "life-threatening" labeling errors

High blood pressure drug recall: FDA warns of potentially "life-threatening" labeling errors



A certain amount of blood pressure medication was recalled after a bottle from this batch was misidentified according to a Food and Drug Administration statement.

  fda_logo.jpg

Kellogg Co. (NYSE: K) announced Thursday that due to possible salmonella contamination, around 1

.3 million cases of Honey Smack cereals will be recalled. The US Food & Drug Administration (FDA) is working with Kellogg to initiate the recall after preliminary evidence has linked the product to more than 60 diseases

The bottle should contain hydrochlorothiazide tablets USP 12.5 mg – a medication for the treatment of hypertension. Instead, they included spironolactone tablets USP 25 mg – used to treat congestive heart failure, cirrhosis and other diseases.

The FDA says the effects of mixing the drugs depend on the individual, but can range from "limited" to "life-threatening."

Accord Healthcare Inc. voluntarily recalled a single batch of the drug, PW05264, after Investigations revealed that it was the only potentially affected batch.

Accord's Hydrochlorothiazide Tablets USP 12.5 mg can be identified by a visual guide. The tablets should be bright orange or peach-colored and round. They have an "H" and a "1" on opposite sides.

For persons holding Accord hydrochlorothiazide tablets that do not conform to this description, the FDA recommends that you check with a pharmacy or health care provider.

Accord says there have been no reports of adverse events related to this recall under FDA clearance.

Copyright 2017 USATODAY.com


Source link